genesis slider

Since 1997, we have been constantly working to ensure that patients in our country have direct access to branded, innovative pharmaceutical products.


GENESIS' Pharma portfolio includes novel branded pharmaceutical products of high therapeutic value, many of which are biotech.
Most of these pharmaceutical products are intended exclusively for hospital use, and are designed to meet therapeutic needs of patients with rare and serious diseases.

 

HEMATOLOGY

 

ICLUSIG® (Ponatinib)
 
Incyte Biosciences UK Ltd
IMNOVID® (Pomalidomide)
 
Celgene Europe Ltd
 

REVLIMID® (Lenalidomide)
 

Celgene Europe Ltd
 

THALIDOMIDE CELGENE®  (Thalidomide)
 

Celgene Europe Ltd
 

VIDAZA® (Azacitidine)
 

Celgene Europe Ltd
 


 ONCOLOGY

 

ABRAXANE® (nanoparticle albumin bound  paclitaxel)
 

Celgene Europe Ltd
 

MEPACT® (Mifamurtide)
 

Takeda Ireland Ltd
 

YONDELIS® (Trabectedin)
 

PharmaMar SA
 


CENTRAL NERVOUS SYSTEM
 

AVONEX® (Interferon Beta-1a)
 

Biogen Idec Ltd
 

FAMPYRA® (Fampridine) 
 

Biogen Idec Ltd
 

PLEGRIDY® (Peginterferon beta-1a)
 

Biogen Idec Ltd
 

SPINRAZA® (Nusinersen)
 
Biogen Idec Ltd
TECFIDERA® (Dimethyl fumarate)
 
Biogen Idec Ltd
TYSABRI® (Natalizumab)
 
Biogen Idec Ltd
 

NEPHROLOGY
 

VELPHORO® (Sucroferric oxyhydroxide)
 

Vifor Fresenius Medical Care Renal Pharma Ltd

   

RHEUMATOLOGY
 

OTEZLA® (Apremilast) Celgene Europe Ltd
BENEPALI® (Etanercept) Samsung Bioepis UK Ltd
   

DERMATOLOGY
 

OTEZLA® (Apremilast)
 

Celgene Europe Ltd
 

   

IRON 
 

FERINJECT®  (Intravenous Iron Carboxymaltose)
 

Vifor France

 

FERRUM HAUSMANN® (Ferric hydroxide polymaltose complex)
 

GENESIS Pharma S.A.
 

FERRUM FOL HAUSMANN® (Ferric hydroxide polymaltose complex, folic acid)
 

GENESIS Pharma S.A.
 

 

 


Note: The companies listed on the right column refer to the Marketing Authorisation Holder of each product